Resources

This evidence brief discusses the rationale for improving immunization information systems and describes user experiences with different types of systems. It also provides advice on feasibility in different contexts. It draws on evidence gathered during project Optimize demonstrations in Albania, Guatemala, Senegal, South Sudan, Tunisia, and Vietnam.

This evidence brief developed by project Optimize is directed toward supply chain managers in low-and middle-income countries and provides information about direct-drive solar refrigerators, which may be a good option for vaccine storage in areas with little or no electricity. It provides background about the technology and some practical guidance about weighing this option for specific situations.

This fact sheet describes the vital role PATH’s advocacy is playing to ensure that policies meet the needs of the most vulnerable people and expand access to lifesaving interventions. PATH's advocacy focuses on cross-cutting issues impacting global health as well as specific health areas such as maternal, newborn, and child health; malaria; and HIV/AIDS.

This fact sheet describes a phase 3 clinical study that PATH and our partners are conducting in Senegal to evaluate the clinical efficacy of a seasonal, trivalent live attenuated influenza vaccine (LAIV). By providing evidence on how well this type of vaccine works among young children in Senegal, this study will help inform efforts in the scientific community to develop optimal LAIVs for the world’s most vulnerable children, as well as policy decisions for potential future LAIV use in Senegal and other tropical, low-resource countries in Africa.

This operational assessment of Sayana® Press in Uganda examines the extent to which Sayana® Press facilitates the logistics of managing and administering injectable contraception and assesses whether providers in Uganda find benefits in this new presentation.